Savient Pharmaceuticals (SVNT) Posts Q1 Loss of 34c/Share

May 15, 2013 7:14 AM EDT
Savient Pharmaceuticals (NASDAQ: SVNT) reported Q1 EPS of ($0.34), $0.03 worse than the analyst estimate of ($0.31). Revenue for the quarter came in at $4.7 million versus the consensus estimate of $5.65 million.

For earnings history and earnings-related data on Savient Pharmaceuticals (SVNT) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings